Movement disorder specialists are neurologists who focus on diagnosing and treating disorders that affect the control of voluntary and involuntary movements. These disorders encompass Parkinson’s disease, essential tremor, dystonia, Huntington’s disease, as well as different types of chorea and myoclonus. Specialists use detailed clinical assessments, neuroimaging, and sometimes genetic testing to accurately diagnose these complex disorders. Their treatment strategies often combine medications, physical therapy, and in some cases, advanced interventions such as deep brain stimulation (DBS). By tailoring treatments to each patient’s unique symptoms and disease progression, movement disorder specialists aim to improve mobility, reduce symptoms, and enhance quality of life.
Movement disorder specialists engage in research to better understand the underlying mechanisms of these neurological diseases and to develop innovative therapies. They often work as part of multidisciplinary teams that include physical therapists, occupational therapists, and speech-language pathologists to address the broad impact of movement disorders on daily living. Advances in neuroimaging, genetics, and neuromodulation have greatly expanded their ability to provide personalized treatment plans. Movement disorder specialists play a vital role in managing chronic neurological conditions, offering hope and improved function to patients facing progressive motor challenges. Their expertise continues to drive progress in both clinical practice and research, ultimately enhancing patient outcomes worldwide.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom